PharmiWeb.com - Global Pharma News & Resources
16-Jan-2019

PEGylated Protein Therapeutics - Worldwide Analysis & Outlook to 2025: A $17.8 Billion Opportunity - ResearchAndMarkets.com

The "PEGylated Protein Therapeutics Market by Product Type, By Application By Sales Channel - Global Opportunity Analysis and Industry Forecast, 2018-2025" report has been added to ResearchAndMarkets.com's offering.

The market was valued at $10,388 million in 2017, and is projected to reach $17,813 million by 2025, growing at a CAGR of 6.9% from 2018 to 2025. North America is anticipated to be the highest revenue contributor throughout the forecast period.

The factors that drive the growth of the global PEGylated protein therapeutics market are increase in prevalence of chronic diseases, advantages offered by PEGylation, and strong presence of pipe line drugs are.

However, high cost related to drug development and launch of generics during the forecast period are expected to impede the market growth.

In addition, high market potential in the untapped emerging economies and increase in adoption of PEGylated protein therapeutics are expected to provide many opportunities during the forecast period.

By product type, the colony stimulating factor segment accounted for nearly half share of the global occupational medicine market in 2017. Furthermore, the cancer segment is anticipated to grow at the highest rate of 7.4% during the forecast period.

Select Findings

  • North America occupied nearly two-thirds share of the global PEGylated protein therapeutics market in 2017
  • The cancer segment is anticipated to grow with the highest CAGR throughout the forecast period
  • Europe is anticipated to occupy one-fifth market share of the global PEGylated protein therapeutics market by 2025
  • Asia-Pacific is anticipated to grow at the highest rate during the analysis period, followed by LAMEA

Key Players

  • Amgen
  • AstraZeneca
  • Biogen
  • F. Hoffmann-La Roche (Genentech)
  • Horizon Pharma
  • Leadiant Biosciences
  • Merck & Co. (Schering-Plough Corporation)
  • Pfizer
  • Shire (Baxalta)
  • UCB

Topics Covered

Chapter 1: Introduction

Chapter 2: Executive Summary

Chapter 3: Market Overview

Chapter 4: PEGylated Protein Therapeutics Market, by Product Type

Chapter 5: PEGylated Protein Therapeutics Market, by Application

Chapter 6: PEGylated Protein Therapeutics Market, by Sales Channel

Chapter 7: PEGylated Protein Therapeutics Market, by Region

Chapter 8: Company Profiles

For more information about this report visit https://www.researchandmarkets.com/research/jw8djl/pegylated_protein?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20190116005330/en/

Editor Details

Last Updated: 16-Jan-2019